A Trial to Assess the Immunogenicity and Safety of the Trivalent Virosomal Influenza Vaccine, Formulation of 2012-2013, in Healthy Subjects Aged Over 3 Years Old to 18 Years Old
Clinical trial NCT01755364 · COMPLETED
Trial details
- NCT number
- NCT01755364
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2013-01-28
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.